Bioviser
Bioviser is a global healthcare and pharmaceutical consulting company dedicated to advancing healthcare through scientific expertise, innovative solutions, and strategic partnerships. They offer a wide range of services including pharmacovigilance, health economics, publication planning, space research, biostatistics, and data analytics. Committed to quality, transparency, and client success, Bioviser leverages technology and scientific knowledge to address complex health challenges and improve patient outcomes worldwide. The company actively engages in cutting-edge research, clinical solutions, and evidence-based health strategies, supporting publication and manuscript writing for global pharmaceutical clients. They also provide expert HEOR services, space health research, and have a strong focus on evidence-based health solutions.
Industries
Nr. of Employees
small (1-50)
Bioviser
Boston, Massachusetts, United States, North America
Services
Design and execution of studies using real-world data to address clinical and market-access evidence needs, including study design, data curation and analysis.
Development of economic models, systematic literature reviews, cost-effectiveness and budget-impact analyses and preparation of value dossiers to inform pricing, reimbursement and market-access strategies.
Managed pharmacovigilance services including case processing (ICSR), safety database operations, coding, medical assessment and regulatory reporting with audit-ready documentation and quality oversight.
Preparation and consolidation of aggregate safety reports for regulatory and compliance needs across multiple jurisdictions.
End-to-end manuscript preparation, journal submission management, peer-review response drafting and publication-policy/SOP development for clinical and observational research.
Medical writing, publication planning, medical review and communication strategies to support scientific dissemination and stakeholder engagement.
Design and execution of studies using real-world data to address clinical and market-access evidence needs, including study design, data curation and analysis.
Development of economic models, systematic literature reviews, cost-effectiveness and budget-impact analyses and preparation of value dossiers to inform pricing, reimbursement and market-access strategies.
Managed pharmacovigilance services including case processing (ICSR), safety database operations, coding, medical assessment and regulatory reporting with audit-ready documentation and quality oversight.
Preparation and consolidation of aggregate safety reports for regulatory and compliance needs across multiple jurisdictions.
End-to-end manuscript preparation, journal submission management, peer-review response drafting and publication-policy/SOP development for clinical and observational research.
Medical writing, publication planning, medical review and communication strategies to support scientific dissemination and stakeholder engagement.
Expertise Areas
- Real-world evidence and RWD analytics
- Claims-database epidemiology and transmission modelling
- Health economics (HEOR) and value-dossier development
- Pharmacovigilance and safety database operations
Key Technologies
- Real-world data (RWD) analytics
- Claims database analysis
- Epidemiological and transmission modelling
- Health-economic modelling and budget-impact analysis
News & Updates
Bioviser helped a distinguished pharma company clear a backlog of cases by onboarding associates and assisted with USFDA audit preparation, resulting in no findings or observations.
Bioviser participated in the Human Research Program Investigators’ Workshop (HRP IWS) in Galveston, TX, focusing on safe and efficient human spaceflight.
Bioviser presented on the public disclosure of clinical research and evidence transparency at the ISPOR 2023 conference.
Analysis of the impact of U.S. drug pricing policies on the global pharmaceutical industry.
Exploring how space research data analytics support clinical and translational research.
Bioviser helped a distinguished pharma company clear a backlog of cases by onboarding associates and assisted with USFDA audit preparation, resulting in no findings or observations.
Bioviser participated in the Human Research Program Investigators’ Workshop (HRP IWS) in Galveston, TX, focusing on safe and efficient human spaceflight.
Bioviser presented on the public disclosure of clinical research and evidence transparency at the ISPOR 2023 conference.
Analysis of the impact of U.S. drug pricing policies on the global pharmaceutical industry.
Exploring how space research data analytics support clinical and translational research.